JANEL CORP financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data JANEL CORP files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	75.3	58.9	67.5	84.4	82.4	146	317	186	183	207
Cost of revenue		40.9	47.2	59.2	58.9	114	251	131	125	142
Gross profit	15.8	18	20.3	25.1	23.5	32.4	66.2	55.7	58.4	65
Selling, general and administrative	13	15.2	18.6	22.6	24.3	27.4	54.7	51	52.3	55.9
Operating expenses	73.2	56.8	19.4	23.5	25.2	28.5	56.7	53.1	54.6	58.6
Operating income	2.16	2.1	0.89	1.58	-1.72	3.95	9.5	2.6	3.76	6.43
Other non-operating income								-0.08	-0.35	2.52
Pre-tax income	1.48	1.37	0.38	0.95	-2.23	6.16	0.05	0.53	1.09	6.88
Income tax	-2.1	0.49	0.13	0.33	-0.51	0.96	2.19	-0.2	0.54	1.22
Income from continuing operations	3.58	0.87	0.25
Net income to minority interests	0.08	0.11
Net income	3.38	0.73	0.25	0.62	-1.73	5.2	-2.14	0.72	0.55	5.66
EBITDA		2.22	0.99	1.86	-1.45	4.32	9.98	3.11	4.31	7.08
EPS, basic	1.70	0.37	1.86	-0.35	-2.75	4.73	-3.03	0.37	0.19	4.24
EPS, diluted	1.56	0.26	1.28	-0.35	-2.75	4.48	-3.03	0.36	0.18	4.17
Shares, basic (weighted)	1.99	0.56	0.57	0.85	0.87	0.94	1.03	1.19	1.19	1.19
Shares, diluted (weighted)	2.17	0.81	0.83	0.85	0.87	0.99	1.03	1.21	1.21	1.21

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	0.97	0.99	0.59	2.16	3.35	6.23	6.59	2.46	2.89	11
Receivables	13.1	15	19.7	21.4	20.2	52.3	57.1	27.5	33.8	66.5
Inventory	0.36	0.35	2.39	4.37	3.67	3.23	4.8	4.85	4.48	4.21
Other current assets	0.23	0.33	0.35	0.67	0.43	3	3.42	4.46	4.83	6.1
Total current assets	14.6	16.6	23.1	28.6	27.7	64.8	71.9	39.3	46	88.8
Property, plant and equipment	0.29	0.39	3.79	3.95	4.98	4.98	5.04	4.92	5.49	5.97
Lease right-of-use assets				0	2.62	2.94	5.66	7.46	8.62	7.76
Goodwill	9.09	9.75	11.5	13.5	14.1	18.5	18.6	20.3	23	31.6
Intangible assets	12.4	11.8	12.3	13.6	13.3	24.2	22.4	22.7	25.1	31
Other non-current assets	21.7	21.7	24.1	27.2	30.4	46.2	49.6	52.6	59.1	76
Total assets	36.6	38.7	50.9	59.7	63	116	127	96.8	111	171
Accounts payable	10	13.3	16.8	22.1	20.8	37.2	45	25.4	32	98.2
Accrued liabilities	1.27	1.57	1.75	2.27	3.01	6.31	7.19	6.34	7.49	5.85
Short-term debt	0.86	0.86	0.9	0.83
Total current liabilities	19.1	23.5	29.6	34.7	38.1	79.6	85	58.8	71.4	121
Long-term debt	4.62	3	3.83	6.6
Lease liabilities				0	1.92	1.75	4	5.69	6.59	6.31
Other non-current liabilities		0.08	0.25	0.33	0.39	0.42	0.38	0.48	0.53	0.29
Total liabilities	25	27.5	35.9	44.8	50.4	97.8	108	77.9	91.1	145
Total debt	5.47	3.86	4.73	7.43
Paid-in capital	5.41	12.3	15.9	15.1	14.6	14.8	17.2	17.1	17.1	17.7
Retained earnings	-1.58	-0.85	-0.61	0.04	-1.68	3.52	1.38	2.11	2.66	8.31
Treasury stock	0	-0.24	-0.24	-0.24	-0.24	-0.24	-0.24	-0.24	-0.24	-0.24
Shareholders' equity	3.83	11.2	15	14.9	12.7	18.1	18.3	19	19.5	25.8
Minority interests	1	1.11								0
Total equity	3.83	11.2	15	14.9	12.7	18.1	18.3	19	19.5	25.8
Total liabilities and equity	36.6	38.7	50.9	59.7	63	116	127	96.8	111	171
Shares outstanding	1.99	0.55	0.82	0.84	0.9	0.94	1.19	1.19	1.19	1.19

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	3.38	0.73	0.25	0.62	-1.73	5.2	-2.14	0.72	0.55	5.66
Depreciation and amortization		0.11	0.1	0.28	0.27	0.37	0.48	0.51	0.55	0.65
Stock-based compensation	0.12	0.32	0.68	0.3	0.27	0.12	0.83	0.23	0.32	0.49
Deferred income tax	-2.21	0.37	0.08	0.22	-0.57	0.73	0.24	-1.25	0.2	-0.26
Change in receivables	0.64	-1.82	-3.94	-0.37	2.49	-20.7	-5.87	29.8	-4.52	-25.2
Change in inventory	0.02	0.01	-0.07	-0.07	-0.17	-0.04	-1.5	0.03	0.04	-0.1
Change in payables	-1.71	2.55	2.55	4.7	-3.19	16.3	8.55	-20.4	5.3	62.9
Cash from operations	1.06	3.19	0.85	7.2	-0.55	-0.2	12.1	11.4	6.83	43.1
Capital expenditures	-0.14	-0.22	-0.09	-0.42	-1.3	-0.23	-0.55
Acquisitions	-4.36	-0.1	-7.39	-6.18	-0.25	-15.9	-0.95	-4.45	-3.85	-11.9
Purchases of investments								0	-0.04	-0.24
Cash from investing	-10.9	-0.2	-7.6	-6.6	-1.54	-16.1	-11.5	-6.5	-5.64	-15.2
Debt issued				2.7	0.01
Debt repaid	-0.5	-1.62	-1.16					-1.75	-2.28
Stock issued		0	0.05	0.07	0.27	0.05	0.28	0	0	0.79
Share buybacks		-0.24	0
Cash from financing	9.82	-2.96	6.35	0.98	3.28	19.2	-0.28	-9.02	-0.57	-18.9
Net change in cash	0.02	0.02	-0.4	1.58	1.19	2.89	0.36	-4.13	0.62	8.96
Free cash flow	0.92	2.97	0.76	6.78	-1.85	-0.44	11.6
Interest paid	0.59	0.75	0.49	0.65	0.51	0.42	0.88	1.86	2	1.58
Income taxes paid	0.11	0.17	0.09	0.15	0.12	0.08	1.88	1.39	0.59	0.86

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $48.00 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	31.8%	Gross profit / revenue.
Operating margin	3.1%	Operating income / revenue.
EBITDA margin	3.4%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	3.5%	Pre-tax income / revenue.
Net margin	2.5%	Net income / revenue.
Operating cash flow margin	19.2%	Cash from operations / revenue.
Effective tax rate	17.2%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	21.7%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	3.1%	Net income / average total assets.
Return on invested capital (ROIC)	262.2%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	27.2%	Selling, general and administrative expense / revenue.
Stock-based pay / revenue	0.1%	Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue	0.3%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	13.2%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-13.2%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	20.3%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	11.3%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-0.6%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	22.5%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	71.2%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-12.2%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA growth, 1y	64.3%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-10.8%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income growth, 1y	926.7%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	2,217.0%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	530.4%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	52.7%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value growth, 1y	32.3%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	12.1%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	15.3%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	54.4%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	10.5%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	22.1%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-0.1%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	5.4%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	6.7%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	0.79x	Current assets / current liabilities.
Quick ratio	0.70x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.26x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.32x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	4.6%	Total debt / total assets.
Liabilities / assets	82.7%	Total liabilities / total assets.
Net debt	-$24.9M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	-3.13x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Working capital	-$27.7M	Current assets - current liabilities.
Goodwill and intangibles / assets	35.9%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$41.7M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.24x	Revenue / average total assets.
Fixed asset turnover	41.9x	Revenue / average property, plant and equipment.
Inventory turnover	27.0x	Cost of revenue / average inventory.
Days inventory	14 days	365 x average inventory / cost of revenue.
Receivables turnover	4.06x	Revenue / average receivables.
Days sales outstanding	90 days	365 x average receivables / revenue.
Days payables	156 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	-53 days	Days inventory + days sales outstanding - days payables.

Per share

Metric	Value	How it is calculated
EPS, diluted	$4.86	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$195.07	Revenue / diluted weighted shares.
Operating cash flow per share	$37.47	Cash from operations / diluted weighted shares.
Book value per share	$22.94	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$35.19	Tangible book value / shares outstanding.
Cash per share	$28.40	(Cash + short-term investments) / shares outstanding.

Valuation

Metric	Value	How it is calculated
Market cap	$56.9M	Share price x shares outstanding.
Enterprise value	$32.0M	Market cap + total debt - cash - short-term investments.
P/E	9.65x	Market cap / net income. Only when net income is positive.
P/S	0.24x	Market cap / revenue.
P/B	2.09x	Market cap / shareholders' equity. Only when equity is positive.
P/OCF	1.25x	Market cap / cash from operations, when positive.
EV/Sales	0.14x	Enterprise value / revenue.
EV/EBIT	4.39x	Enterprise value / operating income, when both are positive.
EV/EBITDA	4.02x	Enterprise value / EBITDA, when both are positive.
Earnings yield	10.4%	Net income / market cap (the inverse of P/E).

What was JANEL CORP's revenue in fiscal 2025?

JANEL CORP reported revenue of $207.4M for fiscal 2025, 13.2% higher than the year before.

Was JANEL CORP profitable in fiscal 2025?

Yes. Net income was $5.7M, a net margin of 2.7%.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to JANEL CORP